Articles From: AeroVironment Solar-Powered Puma AE Small Unmanned Aircraft Achieves Continuous Flight for More Than Nine Hours to AETI Expands Primary Manufacturing Facility to Meet Increased Demand for Turnkey Power Delivery Solutions


At AUVSI – AeroVironment, Inc. (NASDAQ:AVAV) today announced that a recent outdoor test flight of a solar-powered prototype version of the company’s proven Puma AE™ small unmanned aircraft system (UAS), operating with the company’s newest long-endurance battery, lasted 9 hours, 11 minutes – significantly longer than the flight endurance of small UAS being used in the field today.
Sign-up for AeroVironment Solar-Powered Puma AE Small Unmanned Aircraft Achieves Continuous Flight for More Than Nine Hours investment picks
AeroVironment, Inc. (NASDAQ: AVAV) today reported financial results for its first quarter ended July 27, 2013.
Sign-up for AeroVironment, Inc. Announces Fiscal 2014 First Quarter Results investment picks
AeroVironment, Inc. (NASDAQ: AVAV) today reported financial results for its second quarter ended October 26, 2013.
Sign-up for AeroVironment, Inc. Announces Fiscal 2014 Second Quarter Results investment picks
AeroVironment, Inc. (NASDAQ:AVAV) today announced it will issue financial results for the Company's second fiscal quarter ended October 26, 2013, after the market closes on Tuesday, November 26, 2013.
Sign-up for AeroVironment, Inc. Schedules Second Quarter Fiscal 2014 Earnings Release and Conference Call investment picks
SPRINGDALE, Ark., Aug.
Sign-up for AERT Announces 2nd Quarter 2013 Results investment picks
The Board of Directors of The AES Corporation (NYSE:AES) declared a quarterly common stock dividend of 4 cents per share payable November 15, 2013 to shareholders of record at the close of business on November 1, 2013.
Sign-up for AES Announces Quarterly Dividend investment picks
The AES Corporation (NYSE: AES) announced today that it has commenced a registered underwritten public offering of 40 million shares of its common stock (the “Offering”), all of which will be offered by Terrific Investment Corporation (the “Selling Stockholder”), a subsidiary controlled by China Investment Corporation (“CIC”). AES will not receive any of the proceeds from the Offering.
Sign-up for AES Announces Secondary Offering of 40 Million Shares of Common Stock by a Subsidiary of CIC and Concurrent Repurchase of 20 Million Shares of AES Common Stock investment picks
Aeterna Zentaris Announces Closing of US$13.2 Million Public Offering of Common Shares and Warrants Canada NewsWire QUÉBEC CITY, Jan.
Sign-up for Aeterna Zentaris Announces Closing of US$13.2 Million Public Offering of Common Shares and Warrants investment picks
Aeterna Zentaris Announces Closing of US$15.1 Million Public Offering of Common Shares and Warrants Canada NewsWire QUÉBEC CITY, Nov.
Sign-up for Aeterna Zentaris Announces Closing of US$15.1 Million Public Offering of Common Shares and Warrants investment picks
Aeterna Zentaris Announces Listing Transfer to NASDAQ Capital Market Canada NewsWire QUÉBEC CITY, Aug.
Sign-up for Aeterna Zentaris Announces Listing Transfer to NASDAQ Capital Market investment picks
QUÉBEC CITY, Aug.
Sign-up for Aeterna Zentaris Announces Listing Transfer to NASDAQ Capital Market investment picks
QUÉBEC CITY, Nov.
Sign-up for Aeterna Zentaris Announces Proposed Public Offering of Common Shares and Warrants investment picks
Aeterna Zentaris Announces Proposed Public Offering of Common Shares and Warrants Canada NewsWire QUÉBEC CITY, QC, Jan.
Sign-up for Aeterna Zentaris Announces Proposed Public Offering of Common Shares and Warrants investment picks
All amounts are in US dollars QUÉBEC CITY, Nov.
Sign-up for Aeterna Zentaris Appoints Chief Commercial Officer, Reaffirming New Company Vision investment picks
Aeterna Zentaris Appoints Chief Commercial Officer, Reaffirming New Company Vision Canada NewsWire All amounts are in US dollars QUÉBEC CITY, Nov.
Sign-up for Aeterna Zentaris Appoints Chief Commercial Officer, Reaffirming New Company Vision investment picks
QUÉBEC CITY, Jan.
Sign-up for Aeterna Zentaris Appoints Dr. Richard Sachse as Chief Scientific Officer investment picks
Aeterna Zentaris Appoints Dr.
Sign-up for Aeterna Zentaris Appoints Dr. Richard Sachse as Chief Scientific Officer investment picks
Aeterna Zentaris Completes Successful Transfer of Cetrotide® Manufacturing Rights to Merck KGaA Canada NewsWire Company to Receive $3.3 Million One-Time Payment All amounts are in US dollars (unless otherwise mentioned) QUÉBEC CITY, Oct.
Sign-up for Aeterna Zentaris Completes Successful Transfer of Cetrotide® Manufacturing Rights to Merck KGaA investment picks
QUEBEC CITY , Jan.
Sign-up for Aeterna Zentaris NDA for Macimorelin Acetate in AGHD Accepted for Filing by the FDA investment picks
Aeterna Zentaris NDA for Macimorelin Acetate in AGHD Accepted for Filing by the FDA Canada NewsWire QUEBEC CITY , Jan.
Sign-up for Aeterna Zentaris NDA for Macimorelin Acetate in AGHD Accepted for Filing by the FDA investment picks
Aeterna Zentaris Reports Second Quarter 2013 Financial and Operating Results Canada NewsWire All amounts are in U.S. dollars (unless otherwise noted) QUEBEC CITY , Aug.
Sign-up for Aeterna Zentaris Reports Second Quarter 2013 Financial and Operating Results investment picks
Aeterna Zentaris Reports Third Quarter 2013 Financial and Operating Results Canada NewsWire All amounts are in U.S. dollars (unless otherwise noted) QUEBEC CITY , Nov.
Sign-up for Aeterna Zentaris Reports Third Quarter 2013 Financial and Operating Results investment picks
Aeterna Zentaris to Present at Upcoming Rodman & Renshaw Annual Global Investment Conference in New York Canada NewsWire QUÉBEC CITY, Aug.
Sign-up for Aeterna Zentaris to Present at Upcoming Rodman & Renshaw Annual Global Investment Conference in New York investment picks
Aeterna Zentaris: Article on Phase 2 Results for Zoptarelin Doxorubicin in Endometrial Cancer Published in the International Journal of Gynecological Cancer Canada NewsWire QUÉBEC CITY, Feb.
Sign-up for Aeterna Zentaris: Article on Phase 2 Results for Zoptarelin Doxorubicin in Endometrial Cancer Published in the International Journal of Gynecological Cancer investment picks
All amounts are in U.S. dollars (unless otherwise noted) QUÉBEC CITY, July 31, 2013 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company") today announced that the first patient has been recruited and dosed for the Phase 3 ZoptEC ( Zopt arelin doxorubicin in E ndometrial C ancer) trial in women with endometrial cancer resistant to platinum/taxane-based chemotherapy.
Sign-up for Aeterna Zentaris: First Patient Dosed for Phase 3 Registration Trial in Endometrial Cancer with Zoptarelin Doxorubicin (AEZS-108) investment picks
SAN DIEGO , Sept.
Sign-up for Aethlon Medical Announces Renewal of DARPA Dialysis-Like Therapeutics Contract investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: AeroVironment Solar-Powered Puma AE Small Unmanned Aircraft Achieves Continuous Flight for More Than Nine Hours to AETI Expands Primary Manufacturing Facility to Meet Increased Demand for Turnkey Power Delivery Solutions
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity